CD8A and neoplasm: In B16-OVA tumor model and AOM/DSS model, we observed no significant differences in tumor size or numbers between WT and IL-37tg mice when injected with CD8-blocking antibodies (Fig. 4d–f), suggesting that CD8 neutralization eliminated the differences in tumor size or numbers between WT and IL-37tg mice.